Previous close | 116.18 |
Open | 116.94 |
Bid | 115.53 x 800 |
Ask | 117.50 x 1100 |
Day's range | 114.86 - 117.26 |
52-week range | 74.75 - 139.55 |
Volume | |
Avg. volume | 5,113,641 |
Market cap | 44.091B |
Beta (5Y monthly) | 1.13 |
PE ratio (TTM) | 126.95 |
EPS (TTM) | 0.91 |
Earnings date | 07 Feb 2024 - 12 Feb 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 124.60 |
At present, Charles River (CRL) is the largest provider of outsourced drug discovery, non-clinical development and regulated safety testing services worldwide.
In this piece, we will look at the 11 best long-term growth stocks to invest in. If you want to skip our introduction to the current drivers of stock market performance, then check out 5 Best Long term Growth Stocks To Invest In. The year 2023 has proven to be dynamic for the stock market. […]
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.